ABSTRACT
BACKGROUND: Arboviral diseases are a global growing problem due to climate change, urbanization, population density, and global transportation. However, new technologies currently being developed in research labs are expected to play a relevant role in combatting arboviral diseases in the future, reducing the health and economic burden imposed by these diseases. OBJECTIVES: This paper aims to anticipate the technologies that might be relevant for prevention and vector control of arboviral diseases in the future. METHODS: A web-based survey was conducted of over 2,000 experts from all over the world. Both the technologies and the respondents were identified from recent scientific publications on arboviral diseases indexed in the Web of Science Core Collection. RESULTS: Our results show that within 20 years the enveloped virus-like particles-based vaccine and the gene-edited mosquitoes through CRISPR/Cas9 will likely be the most promising technologies for, respectively, prevention and vector control of arboviral diseases. CONCLUSIONS: If these expectations are confirmed, these new technologies, when fully developed, may support global public health efforts aimed at reducing transmission, mortality and morbidity of arboviral diseases.
Subject(s)
Arbovirus Infections/prevention & control , Arboviruses/physiology , Culicidae/virology , Mosquito Vectors/physiology , Animals , Arbovirus Infections/epidemiology , Arbovirus Infections/transmission , Arbovirus Infections/virology , Culicidae/genetics , Culicidae/physiology , Humans , Mosquito Control , Mosquito Vectors/genetics , Mosquito Vectors/virology , Public Health , Viral Vaccines/administration & dosageABSTRACT
The aim of this paper is to map the scientific landscape related to cancer research worldwide between 2012 and 2017. We use scientific publication data from Web of Science Core Collection and combine bibliometrics and social network analysis techniques to identify the most relevant journals, research areas, countries and research organizations in cancer scientific landscape. The results show: Oncotarget as the journal with most publications; a significant increase in China's publications, reaching United States' publications in 2017; MD Cancer Center, University of California and Harvard University as organizations with most publications; cell biology as the most frequent research area; breast, lung and colorectal cancer as the most frequent keywords; high density of co-authorship between organizations in the West, especially in the US, and low density between organizations in Asian and lower and medium income countries. Our findings can be used to guide a global knowledge platform guiding policy, planning and funding decisions as well as to establish new institutional collaborations.
